Effects of synthetic and natural in vivo inhibitors of ß- glucuronidase on azoxymethane-induced colon carcinogenesis in rats

Molecular Medicine Reports

Volumn 1, Issue 5, 2008, Pages 741-746

  Morita, Nanae ^a   Walaszek, Zbigniew ^c   Kinjo, Tatsuya ^a,c   Nishimaki, Tadashi ^a   Hanausek, Margaret ^c   Slaga, Thomas J ^c   Mori, Hideki ^b   Yoshimi, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c University of Texas Health Science Center at San Antonio   (United States)

Author keywords

glucuronidase; 2,5 di O acetyl D glucaro 1,4:6,3 dilactone; Azoxymethane; Colon carcinogenesis; D glucurono lactone

Indexed keywords

ACEGLATONE; AZOXYMETHANE; BETA GLUCURONIDASE INHIBITOR; DEXTRO GLUCURONO GAMMA LACTONE; GLYCOSIDASE INHIBITOR; LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCI; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; COLON CARCINOGENESIS; COLON DISEASE; COLON TUMOR; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG INHIBITION; DRUG MECHANISM; ENZYME SYNTHESIS; IN VIVO STUDY; MALE; NONHUMAN; POSTOPERATIVE CARE; PROPHYLAXIS; RAT; TUMOR LOCALIZATION;

RATTUS; RODENTIA;

EID: 69449108115     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000022     Document Type: Article

References (35)

1. Weisburger JH: Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am J Clin Nutr 53: S226-S237, 1991.
2. Tanaka T: Chemoprevention of colon carcinogenesis by non-nutritive compounds in foods. In: Carcinogenic and Anti-carcinogenic Factors in Food. Eisenbrand G, Dayan A, Elis P, Grunow W and Schlatter J (eds). Wiley-VCH, Weinheim, pp365-391, 2000.
3. Sharma RA, Manson MM, Gescher A and Steward WP: Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents. Eur J Cancer 37: 12-22, 2001. (Pubitemid 32119355)
4. Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K and Ohigashi H: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate. Jpn J Cancer Res 88: 821-830, 1997. (Pubitemid 27475083)
5. Mori H, Tanaka T, Shima H, Kuniyasu T and Takahashi M: Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett 30: 49-54, 1986. (Pubitemid 16174681)
6. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K and Ohigashi H: Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 58: 2550-2556, 1998. (Pubitemid 28275424)
7. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T and Ogawa H: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18: 957-965, 1997. (Pubitemid 28132340)
8. Tanaka T, Kojima T, Suzui M and Mori H: Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res 53: 3908-3913, 1993. (Pubitemid 23267687)
9. Dutton G: Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, FL, 1980.
10. Walaszek Z: Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett 54: 1-8, 1990.
11. Dohrmann R: ß-Glucuronidase. Springer-Verlag, Berlin, 1969.
12. Boyland E, Wallace DM and Williams DC: Enzyme activity in relation to cancer: inhibition of urinary beta-glucuronidase of patients with cancer of the bladder by oral administration of 1:4-saccharolactone and related compounds. Br J Cancer 11: 578-589, 1957.
13. Walaszek Z, Hanausek-Walaszek M and Webb TE: Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4:6,3-dilactone, an in vivo beta-glucuronidase inhibitor. Carcinogenesis 5: 767-772, 1984.
14. Walaszek Z, Hanausek-Walaszek M, Minton JP and Webb TE: Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a] anthracene-induced mammary tumorigenesis. Carcinogenesis 7: 1463-1466, 1986.
15. Walaszek Z: Chemopreventive properties of D-glucaric acid derivatives. Cancer Bull 45: 453-457, 1993.
16. Takada H, Hirooka T, Hiramatsu Y and Yamamoto M: Effect of beta-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Res 42: 331-334, 1982. (Pubitemid 12207287)
17. Ito N, Hiasa Y, Kamanoto Y, Makiara S, Okajima E, Hiramatsu T, Motomiya Y and Ishikawa M: The effects of 2,5-di-O-acetyl-Dglucosaccharo-1:4,6:3 dilactone (SLA) on the urinary bladder tumors in rats induced with N-butyl-N-(4- hydroxybutyl) nitrosamin. Jpn J Cancer Clin 16: 995-1001, 1970.
18. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA and Stellato TA: Aberrant crypts: putative preneo-plastic foci in human colonic mucosa. Cancer Res 51: 1564-1567, 1991.
19. Pereira MA, Barnes LH, Rassman VL, Kelloff GV and Steele VE: Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis 15: 1049-1054, 1994.
20. Wattenberg LW: Chemoprevention of cancer. Cancer Res 45: 1-8, 1985.
21. Bertagnolli MM, McDougall CJ and Newmark HL: Colon cancer prevention: intervening in a multistage process. Proc Soc Exp Biol Med 216: 266-274, 1997. (Pubitemid 27449574)
22. Walaszek Z, Hanausek M and Slaga TJ: Mechanisms of chemo-prevention. Chest 125: 128S-133S, 2004.
23. Mori H, Sugie S, Yoshimi N, Hara A and Tanaka T: Control of cell proliferation in cancer prevention. Mutat Res 428: 291-298, 1999. (Pubitemid 29389700)
24. Kurki P, Ogata K and Tan EM: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 109: 49-59, 1988. (Pubitemid 18093761)
25. Roels S, Tilmant K and Ducatelle R: PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol 121: 13-24, 1999. (Pubitemid 29332698)
26. Ward JM: Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 30: 505-513, 1974.
27. Mori H, Mori Y, Tanaka T, Yoshimi N, Sugie S, Kawamori T and Narisawa T: Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats. Carcinogenesis 13: 2217-2220, 1992. (Pubitemid 23022959)
28. Wang A, Yoshimi N, Tanaka T and Mori H: Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett 75: 73-78, 1993. (Pubitemid 24014529)
29. Burdette WJ: Colorectal carcinogenesis. Cancer 34 (Suppl): 872-877, 1974.
30. Parsonnet J: Bacterial infection as a cause of cancer. Environ Health Perspect 103 (Suppl 8): 263-268, 1995.
31. McLellan EA and Bird RP: Aberrant crypts: potential preneo-plastic lesions in the murine colon. Cancer Res 48: 6187-6192, 1988.
32. Pretlow TP, O'Riordan MA, Somich GA, Amini SB and Pretlow TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13: 1509-1512, 1992.
33. Cohen SM and Ellwein LB: Cell proliferation in carcinogenesis. Science 249: 1007-1011, 1990.
34. Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J and Slaga TJ: Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. Int J Oncol 16: 43-48, 2000.
35. Walaszek Z, Hanausek M, Sherman U, Del Rio M and Adams A: Effects of (+) glucaric acid derivatives and tamoxifen on human breast cancer cells (MCF-7). Breast Cancer Res Treat 14: 175, 1989.